PAUL EDWARDS: Open Payments
NPI 1114902558 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$473 in 23 payments from 19 companies in 2025. Trend: 2023 $243 · 2024 $365 · 2025 $473
Food & beverage: $473
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $56 |
| Edwards Lifesciences Corporation | 1 | $43 |
| Xeris Pharmaceuticals, Inc. | 2 | $40 |
| GlaxoSmithKline, LLC. | 1 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| SANOFI-AVENTIS U.S. LLC | 1 | $22 |
| ABBVIE INC. | 1 | $22 |
| SANOFI PASTEUR INC. | 1 | $22 |
| Medtronic, Inc. | 1 | $21 |
Products named: Edwards SAPIEN 3 Ultra Transcatheter Heart Valve, SHINGRIX, LEQVIO, GVOKE HYPOPEN, TZIELD, QULIPTA, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, SYMPLICITY G3.
Industry payments across CO — which companies pay providers there.
